Aligos Therapeutics (ALGS) Other Working Capital Changes (2019 - 2026)
Aligos Therapeutics (ALGS) reported Other Working Capital Changes of -$318000.0 for Q1 2026, down 110.6% on a YoY basis from $3.0 million in Q1 2025, and down 114.46% quarter-over-quarter from $2.2 million in Q4 2025.
Aligos Therapeutics (ALGS) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Aligos Therapeutics has reported Other Working Capital Changes for 8 years, with the latest figure at -$318000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 110.6% year-over-year to -$318000.0; the trailing twelve-month figure through Mar 2026 stood at -$263000.0 (up 89.99% YoY), and the FY2025 full-year result was -$96000.0, up 96.42% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$318000.0, down from $2.2 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $12.4 million in Q2 2022, with the low at -$14.9 million in Q3 2022.
- Historically, Other Working Capital Changes has averaged -$767529.4 across 5 years, with a median of -$796000.0 in 2025.
- The largest YoY upside for Other Working Capital Changes was 674.58% in 2022 against a maximum downside of 1094.72% in 2022.
- Aligos Therapeutics' Other Working Capital Changes stood at $4.3 million in 2022, then sank by 207.24% to -$4.7 million in 2023, then jumped by 56.53% to -$2.0 million in 2024, then surged by 208.49% to $2.2 million in 2025, then sank by 114.46% to -$318000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$318000.0 (Q1 2026), $2.2 million (Q4 2025), and -$796000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Aligos Therapeutics | 51.70 Mn | -28.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -318,000.00 |
| Mar 31, 2026 | -318,000.00 |
| Dec 31, 2025 | 2.20 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Sep 30, 2025 | -796,000.00 |
| Sep 30, 2025 | -796,000.00 |
| Jun 30, 2025 | -1.35 Mn |
| Jun 30, 2025 | -1.35 Mn |
| Mar 31, 2025 | -151,000.00 |
| Mar 31, 2025 | -151,000.00 |
| Dec 31, 2024 | -2.03 Mn |
| Dec 31, 2024 | -2.03 Mn |
| Sep 30, 2024 | 614,000.00 |
| Sep 30, 2024 | 614,000.00 |
| Jun 30, 2024 | -1.06 Mn |
| Jun 30, 2024 | -1.06 Mn |
| Mar 31, 2024 | -204,000.00 |
| Mar 31, 2024 | -204,000.00 |
| Dec 31, 2023 | -4.66 Mn |
| Dec 31, 2023 | -4.66 Mn |